PyInvesting

Market research

002287.SHE Tibet Cheezheng Tibetan Medicine Co., Ltd

SHE CNY Healthcare

Latest close

17.83 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
10B
P/E ratio
15.92
Analyst target
Not available
Dividend yield
3.5%
Beta
0.24

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Tibet Cheezheng Tibetan Medicine Co., Ltd is currently in a long term uptrend where the price is trading 4.8% above its 200 day moving average.

From a valuation standpoint, the stock is 9.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.7.

Tibet Cheezheng Tibetan Medicine Co., Ltd's total revenue sank by 6.7% to $403M since the same quarter in the previous year.

Its net income has increased by 16.2% to $103M since the same quarter in the previous year.

Finally, its free cash flow fell by 217.1% to $-143M since the same quarter in the previous year.

Based on the above factors, Tibet Cheezheng Tibetan Medicine Co., Ltd gets an overall score of 3/5.